Month: June 2013

CHICAGO (AP) — New research raises fresh questions about which cancer patients benefit from Avastin, a drug that lost its approval for treating breast cancer nearly two years ago.

MUMBAI, India (AP) — A simple vinegar test slashed cervical cancer death rates by one-third in a remarkable study of 150,000 women in the slums of India, where the disease is the top cancer killer of women.

By Bill Berkrot (Reuters) – Roche Holding AG’s drug Avastin helped prolong the lives of women with advanced cervical cancer when added to chemotherapy in a late-stage clinical trial, likely paving the way to another major use for the multibillion-dollar medicine. This marked the first study to demonstrate that a drug which blocks blood vessel formation in the tumor can prolong the lives of women with gynecologic cancers, researchers said. …

By Deena Beasley CHICAGO (Reuters) – Breast cancer is less likely to recur if women previously treated for the disease take the drug tamoxifen for 10 years, instead of the recommended five years, according to a British study. The study was a component of a larger international trial, for which similar results were announced last year. “I think it’s huge because it’s the second trial to show a benefit for 10 years versus five years,” said Dr. Sandra Swain, medical director of the Cancer Institute at Washington Hospital Center and president of the American Society of Clinical Oncology, or ASCO. …

PRAGUE (AP) —